Appropriate calibration curve fitting in ligand binding assays

被引:0
|
作者
John W. A. Findlay
Robert F. Dillard
机构
[1] Pfizer Global Research and Development,Pharmacokinetics, Dynamics, and Metabolism
[2] Gilead Sciences Inc,BioStatistics and Data Management
[3] Takeda Pharmaceuticals North America,undefined
[4] Inc,undefined
来源
关键词
Ligand-binding assay; nonlinear calibration; 4/5-parameter logistic models; assay design parameters;
D O I
暂无
中图分类号
学科分类号
摘要
Calibration curves for ligand binding assays are generally characterized by a nonlinear relationship between the mean response and the analyte concentration. Typically, the response exhibits a sigmoidal relationship with concentration. The currently accepted reference model for these calibration curves is the 4-parameter logistic (4-PL) model, which optimizes accuracy and precision over the maximum usable calibration range. Incorporation of weighting into the model requires additional effort but generally results in improved calibration curve performance. For calibration curves with some asymmetry, introduction of a fifth parameter (5-PL) may further improve the goodness of fit of the experimental data to the algorithm. Alternative models should be used with caution and with knowledge of the accuracy and precision performance of the model across the entire calibration range, but particularly at upper and lower analyte concentration areas, where the 4-and 5-PL algorithms generally outperform alternative models. Several assay design parameters, such as placement of calibrator concentrations across the selected range and assay layout on multiwell plates, should be considered, to enable optimal application of the 4- or 5-PL model. The fit of the experimental data to the model should be evaluated by assessment of agreement of nominal and model-predicted data for calibrators.
引用
收藏
相关论文
共 50 条